Non–Vitamin K Antagonist Oral Anticoagulants in Elderly (≥85 years) Patients With Newly Diagnosed Atrial Fibrillation

2019 AHA/ACC/HRS Focused Update of the 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation

(2019) Craig T. January et al.   CIRCULATION

Oral Anticoagulation in Very Elderly Patients With Atrial Fibrillation

(2018) Tze-Fan Chao et al.   CIRCULATION

Age threshold for the use of non-vitamin K antagonist oral anticoagulants for stroke prevention in patients with atrial fibrillation: insights into the optimal assessment of age and incident comorbidities

(2018) Tze-Fan Chao et al.   EUROPEAN HEART JOURNAL

Influence of Direct Oral Anticoagulants on Rates of Oral Anticoagulation for Atrial Fibrillation

(2017) Lucas N. Marzec et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

5-Year Outcomes After Left Atrial Appendage Closure

(2017) Vivek Y. Reddy et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

The Changing Landscape for Stroke Prevention in AF

(2017) Menno V. Huisman et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

The ABC pathway: an integrated approach to improve AF management

(2017) Gregory Y. H. Lip   Nature Reviews Cardiology

Cessation of oral anticoagulation is an important risk factor for stroke and mortality in atrial fibrillation patients

(2017) José Miguel Rivera-Caravaca et al.   THROMBOSIS AND HAEMOSTASIS

Regional Differences in Antithrombotic Treatment for Atrial Fibrillation: Insights from the GLORIA-AF Phase II Registry

(2017) Michał Mazurek et al.   THROMBOSIS AND HAEMOSTASIS

Stroke prevention in atrial fibrillation: Past, present and future

(2017) Ben Freedman et al.   THROMBOSIS AND HAEMOSTASIS

Evolving antithrombotic treatment patterns for patients with newly diagnosed atrial fibrillation

(2016) A John Camm et al.   HEART

Bleeding risk assessment in atrial fibrillation: observations on the use and misuse of bleeding risk scores

(2016) G. Y. H. Lip et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

European Society of Cardiology Guideline-Adherent Antithrombotic Treatment and Risk of Mortality in Asian Patients with Atrial Fibrillation

(2016) Cheng-Hung Li et al.   Scientific Reports

Validating the diagnosis of acute ischemic stroke in a National Health Insurance claims database

(2015) Cheng-Yang Hsieh et al.   JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION

Continuation of statin therapy and a decreased risk of atrial fibrillation/flutter in patients with and without chronic kidney disease

(2013) Chia-Hsuin Chang et al.   ATHEROSCLEROSIS

Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials

(2013) Christian T Ruff et al.   LANCET

2012 focused update of the ESC Guidelines for the management of atrial fibrillation

(2012) et al.   EUROPACE

Are Atrial Fibrillation Patients Receiving Warfarin in Accordance with Stroke Risk?

(2010) Peter J. Zimetbaum et al.   AMERICAN JOURNAL OF MEDICINE

Underuse of Oral Anticoagulants in Atrial Fibrillation: A Systematic Review

(2010) Isla M. Ogilvie et al.   AMERICAN JOURNAL OF MEDICINE

Validation of the national health insurance research database with ischemic stroke cases in Taiwan

(2010) Ching-Lan Cheng et al.   PHARMACOEPIDEMIOLOGY AND DRUG SAFETY

Refining Clinical Risk Stratification for Predicting Stroke and Thromboembolism in Atrial Fibrillation Using a Novel Risk Factor-Based Approach

(2009) Gregory Y.H. Lip et al.   CHEST

Dabigatran versus Warfarin in Patients with Atrial Fibrillation

(2009) Stuart J. Connolly et al.   NEW ENGLAND JOURNAL OF MEDICINE